A Study in Patients With Advanced or Metastatic Cancer
NCT01115751
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Metastases, Neoplasm
Interventions
DRUG:
LY2780301
Sponsor
Eli Lilly and Company